Friday, March 1, 2019

Protein content as a marker for response to therapy in brain cancer

Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein content of tumors correlates with response to treatment and survival.

from Top Health News -- ScienceDaily https://ift.tt/2BZL52A

No comments:

Post a Comment

Popular weight-loss drugs Ozempic and Wegovy may slow biological aging

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking...